Swartz Investments, LLC v. Vion Pharmaceuticals, Inc.

556 S.E.2d 460, 252 Ga. App. 365, 2001 Fulton County D. Rep. 3391, 2001 Ga. App. LEXIS 1285
CourtCourt of Appeals of Georgia
DecidedNovember 8, 2001
DocketA01A1316
StatusPublished
Cited by16 cases

This text of 556 S.E.2d 460 (Swartz Investments, LLC v. Vion Pharmaceuticals, Inc.) is published on Counsel Stack Legal Research, covering Court of Appeals of Georgia primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
Swartz Investments, LLC v. Vion Pharmaceuticals, Inc., 556 S.E.2d 460, 252 Ga. App. 365, 2001 Fulton County D. Rep. 3391, 2001 Ga. App. LEXIS 1285 (Ga. Ct. App. 2001).

Opinion

Pope, Presiding Judge.

In June 1997, Swartz Investments, LLC entered into a letter of agreement in which it agreed to assist Vion Pharmaceuticals, Inc. with a private placement to raise financing for Vion. By the end of August 1997, Swartz and Vion were able to raise $4,850,000 in financing from a number of investors. In connection with that financing, the parties signed a Placement Agent Agreement, containing a *366 “Non-Circumvention & Confidentiality of Proprietary Agent Information” clause.

The “Non-Circumvention” clause can be read in two parts. 1 The first part prohibits Vion for a five-year period from directly or indirectly contacting or negotiating with six named investors regarding an investment in Vion or any other company without Swartz’s prior written permission. This portion also prevents Vion from entering into “any agreement or transaction” with the named investors or disclosing their names for the same time period without Swartz’s permission. The second part requires that Vion pay Swartz a five percent commission should Vion accept an investment from one of the named investors through another agent within one year of the date of the “Last Closing” as defined in the subscription agreement.

Swartz contends that in June 1998, Vion directly contacted several of the investors identified in the noncircumvention clause as part of another private placement, which resulted in approximately $5,000,000 in additional financing. After learning of this, Swartz requested a five percent commission under the clause. Vion acquiesced and paid Swartz $250,000. Swartz asserts that nearly a year later, Vion again contacted Swartz investors, without Swartz’s knowledge, and solicited additional financing. The company raised approximately $4,000,000 in total financing in this private placement. This time, Vion refused Swartz’s request for a five percent commission.

Swartz subsequently sued Vion to recover its commission and alleged claims for breach of contract and quantum meruit. Vion filed *367 a counterclaim seeking declaratory judgment stating that the noncircumvention clause was an unenforceable restrictive covenant and requesting the return of the $250,000 fee it paid to Swartz in 1998. Vion moved for summary judgment on Swartz’s claims and its counterclaim. After hearing oral argument, the trial court granted Vion summary judgment as to Swartz’s claims, finding that the noncircumvention clause was an unenforceable restrictive covenant. 2 Swartz appeals.

1. Swartz argues that the trial court erred in its ruling because it contends that the noncircumvention clause is not a restrictive covenant and that the court should have applied a standard contract analysis to enforce the clause. This issue appears to be a question of first impression in Georgia.

Georgia law interprets restrictive covenants to be in partial restraint of trade and demands that they must meet several criteria in order to be enforceable: “[A] restrictive covenant... is considered to be in partial restraint of trade and will be upheld if the restraint imposed is [reasonable], is founded on a valuable consideration, and is reasonably necessary to protect the interest of the party in whose favor it is imposed, and does not unduly prejudice the interests of the public.” W. R. Grace & Co. v. Mouyal, 262 Ga. 464, 465 (1) (422 SE2d 529) (1992), quoting Rakestraw v. Lanier, 104 Ga. 188, 194 (30 SE 735) (1898).

Georgia courts have considered a number of different contractual provisions to be restrictive covenants, including covenants not to disclose and utilize confidential business information, 3 noncompetition clauses, 4 and nonsolicitation clauses. 5 A characteristic shared by each of these provisions is a prohibition, or at the very least a limitation, placed by one party on the other party’s future business activities.

The noncircumvention provision in this case seeks to limit Vion’s ability to conduct business directly or indirectly with the six named investors for a five-year period. Under the clause, Vion must obtain Swartz’s written permission before it can contact or negotiate with the investors regarding any further investment in Vion or any other company and before it enters into any agreement or transaction of any nature with those investors. These limitations upon Vion’s future *368 actions are in partial restraint of trade, and the clause must be considered as a restrictive covenant.

Swartz argues, however, that we should view the clause as more akin to those found in employment placement or real estate listing contracts that provide that the employment agency or the real estate agent will be paid if the client consummates a transaction with someone found by the agent. See, e.g., Avanti Group (USA.) v. Robert Half of Atlanta, Inc., 198 Ga. App. 366 (401 SE2d 576) (1991) (employment placement agency agreement); Kenney v. Clark, 120 Ga. App. 16 (169 SE2d 357) (1969) (exclusive real estate listing contract). But those provisions generally protect the agency’s or the realtor’s right to be compensated for services performed in the contemplated transaction (e.g., finding the client an employer with a suitable job opening or finding a buyer for a seller’s property).

In this case, however, Swartz was compensated for the services performed in the contemplated transaction; it earned a five percent fee for finding investors for the $5 million private placement that was the subject of the Placement Agent Agreement. The noncircumvention clause does not address that compensation. Rather, it seeks to limit Vion’s right to engage in future transactions with those investors, even if completely unrelated to an investment in Vion, for five years. Accordingly, we will analyze the noncircumvention clause as a restrictive covenant.

2. Next, we must determine the appropriate level of scrutiny to apply in reviewing the clause. Georgia courts apply three different levels of scrutiny to restrictive covenants depending generally upon whether the contract at issue is an employment contract, a contract for the sale of a business, or a professional partnership agreement:

Traditionally Georgia courts divide restrictive covenants into covenants ancillary to an employment contract, which receive strict scrutiny and are not blue-penciled, and covenants ancillary to a sale of business, which receive much less scrutiny and may be blue-penciled. There is also a middle level of scrutiny applicable to covenants found in professional partnership agreements.

(Footnotes omitted.) Northside Hosp. v. McCord, 245 Ga. App. 245, 247 (1) (537 SE2d 697) (2000).

Of course, not every contract falls directly into one of these three categories. Nor do we believe that the type of contract should automatically determine the applicable level of scrutiny. Rather, we must look to the purposes behind the varying levels of scrutiny to deter

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Ryanne Early v. Mimedx Group, Inc.
768 S.E.2d 823 (Court of Appeals of Georgia, 2015)
General Assurance of America, Inc. v. Overby-Seawell Co.
893 F. Supp. 2d 761 (E.D. Virginia, 2012)
Paragon Technologies, Inc. v. InfoSmart Technologies, Inc.
718 S.E.2d 357 (Court of Appeals of Georgia, 2011)
Michael A. Mohr v. Bank of New York Mellon Corp.
371 F. App'x 10 (Eleventh Circuit, 2010)
Onbrand Media v. Codex Consulting, Inc.
687 S.E.2d 168 (Court of Appeals of Georgia, 2009)
CASUAL MALE RETAIL GROUP, INC. v. Yarbrough
527 F. Supp. 2d 172 (D. Massachusetts, 2007)
Glisson v. Global Security Services, LLC
653 S.E.2d 85 (Court of Appeals of Georgia, 2007)
Malice v. Coloplast Corp.
629 S.E.2d 95 (Court of Appeals of Georgia, 2006)
Palmer & Cay, Inc. v. Marsh & McLennan Companies, Inc.
404 F.3d 1297 (Eleventh Circuit, 2005)
Albany Bone & Joint Clinic, P.C. v. Hajek
612 S.E.2d 509 (Court of Appeals of Georgia, 2005)
Hostetler v. Answerthink, Inc.
599 S.E.2d 271 (Court of Appeals of Georgia, 2004)
Holsapple v. Smith
599 S.E.2d 28 (Court of Appeals of Georgia, 2004)
West Coast Cambridge, Inc. v. Rice
584 S.E.2d 696 (Court of Appeals of Georgia, 2003)

Cite This Page — Counsel Stack

Bluebook (online)
556 S.E.2d 460, 252 Ga. App. 365, 2001 Fulton County D. Rep. 3391, 2001 Ga. App. LEXIS 1285, Counsel Stack Legal Research, https://law.counselstack.com/opinion/swartz-investments-llc-v-vion-pharmaceuticals-inc-gactapp-2001.